4,0
17 mei 2026
Voormalige werknemer, meer dan 10 jaar
Boston, MA
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Good company benefits. Strong leadership in Oncology Account Group segment. Pipeline from 2029 and beyond looks strong. The Oncology Key Account Role offers a lot of diverse experiences and is an asset to the teams
Minpunten
Does not pay at high level in comparison to other smaller companies in sales/ commercial side.